IPO Comments to USTR Regarding 2024 Notorious Markets
IPO Comments to USTR Regarding 2024 Notorious Markets
IPO Comments to USTR Regarding 2024 Notorious Markets
RESOLVED, IPO opposes the Medication Affordability and Patent Integrity Act [...]
IPO Comments to CNIPA on Draft Measures for Administrative Adjudication [...]
IPO Comments to CNIPA on Draft Provisions on Procedures for [...]
IPO Comments to USPTO on Impact of Proliferation of AI [...]
IPO Comments to USPTO Regarding Terminal Disclaimer Practice to Obviate [...]
IPO Comments to USPTO on Negotiations at the World Intellectual [...]
IPO Amicus Brief in Cellect v. Vidal, 23-1231
IPO Comments to USPTO on Proposed Changes to PTAB Rules [...]
IPO Comments to USPTO Concerning Rules Governing Director Review of [...]